MAR
71
3
MA
55
4
BEN
55
2
MMM
56
2
ESS
40
-5
BA
47
4
FITB
75
2
KIM
50
-3
O
33
2
FLS
61
13
BWA
53
-7
WAT
49
2
HAL
50
2
ISRG
71
4
JPM
70
3
CMI
71
2
DD
45
-7
D
41
-4
AES
47
-3
AMGN
34
3
MAR
71
3
MA
55
4
BEN
55
2
MMM
56
2
ESS
40
-5
BA
47
4
FITB
75
2
KIM
50
-3
O
33
2
FLS
61
13
BWA
53
-7
WAT
49
2
HAL
50
2
ISRG
71
4
JPM
70
3
CMI
71
2
DD
45
-7
D
41
-4
AES
47
-3
AMGN
34
3
Financhill
Back

Vanguard Short-Term Tax-Exempt Bond ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison

Sell
48

VTES
Vanguard Short-Term Tax-Exempt Bond ETF

Last Price:
$101.60
Seasonality Move:
1.31%
Buy
59

REGN
Regeneron Pharmaceuticals, Inc.

Last Price:
$779.28
Seasonality Move:
12.13%
Sell
48
Vanguard Short-Term Tax-Exempt Bond ETF (VTES) is a Sell

Is Vanguard Short-Term Tax-Exempt Bond ETF a Buy, Sell or Hold?

  • The current Vanguard Short-Term Tax-Exempt Bond ETF [VTES] share price is $101.59. The Score for VTES is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • VTES is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN) is a Buy

Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $767.96. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
  • REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VTES Stock Price Chart

What is Vanguard Short-Term Tax-Exempt Bond ETF's stock price today?

  • The Vanguard Short-Term Tax-Exempt Bond ETF share price today is $101.59
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTES is experiencing buying pressure, which is a positive indicator for future bullish movement.

REGN Stock Price Chart

What is Regeneron Pharmaceuticals, Inc.'s stock price today?

  • The Regeneron Pharmaceuticals, Inc. share price today is $767.96
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing buying pressure, which is a positive indicator for future bullish movement.

VTES Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 19.1 Buy
Relative Strength Index (14 RSI): 55.82 Buy
Chaikin Money Flow: 100142 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (101.43 - 101.59) Buy
Bollinger Bands (100): (101.41 - 101.89) Sell

REGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 142.35 Buy
Relative Strength Index (14 RSI): 64.22 Buy
Chaikin Money Flow: 1264020 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (712.01 - 765.19) Buy
Bollinger Bands (100): (552.57 - 698.59) Buy

VTES Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 101.54 Buy
20-day SMA: 101.52 Buy
50-day SMA: 101.55 Buy
200-day SMA: 101.04 Buy
8-day EMA: 53.79 Buy
20-day EMA: 26.35 Buy
50-day EMA: 11.49 Buy
200-day EMA: 3 Buy

REGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 747.47 Buy
20-day SMA: 745.1 Buy
50-day SMA: 678.03 Buy
200-day SMA: 600.91 Buy
8-day EMA: 400.86 Buy
20-day EMA: 196.11 Buy
50-day EMA: 85.47 Buy
200-day EMA: 22.33 Buy

Vanguard Short-Term Tax-Exempt Bond ETF Earnings Growth & VTES Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.

Vanguard Short-Term Tax-Exempt Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Regeneron Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):